Invention Grant
- Patent Title: Checkpoint regulator antagonists
-
Application No.: US15858963Application Date: 2017-12-29
-
Publication No.: US10537637B2Publication Date: 2020-01-21
- Inventor: Jackie Z. Sheng , Bo Liu
- Applicant: GENSUN BIOPHARMA INC.
- Applicant Address: US CA Newbury Park
- Assignee: Gensun Biopharma Inc.
- Current Assignee: Gensun Biopharma Inc.
- Current Assignee Address: US CA Newbury Park
- Agency: Morris, Manning & Martin, LLP
- Agent Michael X. Ye
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P35/00 ; A61K38/17
Abstract:
Checkpoint regulator antagonists that bind specifically to TIGIT, PD-1 and/or PD-L1 are disclosed. Also disclosed are methods of making and using the checkpoint regulator inhibitors, including monospecific, bispecific and trispecific checkpoint regulator antagonists thereof.
Public/Granted literature
- US20180185482A1 CHECKPOINT REGULATOR ANTAGONISTS Public/Granted day:2018-07-05
Information query
